Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIVEP1 | hg38_v1_chr6_+_12012304_12012338 | 0.42 | 1.6e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106335613 Show fit | 10.07 |
ENST00000603660.1
|
immunoglobulin heavy variable 3-30 |
|
chr14_-_106235582 Show fit | 9.12 |
ENST00000390607.2
|
immunoglobulin heavy variable 3-21 |
|
chr12_-_9760893 Show fit | 8.30 |
ENST00000228434.7
ENST00000536709.1 |
CD69 molecule |
|
chr14_-_106593319 Show fit | 7.91 |
ENST00000390627.3
|
immunoglobulin heavy variable 3-53 |
|
chr14_-_106062670 Show fit | 7.88 |
ENST00000390598.2
|
immunoglobulin heavy variable 3-7 |
|
chr14_-_106360320 Show fit | 7.84 |
ENST00000390615.2
|
immunoglobulin heavy variable 3-33 |
|
chr14_-_105856183 Show fit | 7.84 |
ENST00000637539.2
ENST00000390559.6 |
immunoglobulin heavy constant mu |
|
chr14_-_106675544 Show fit | 7.06 |
ENST00000390632.2
|
immunoglobulin heavy variable 3-66 |
|
chr14_-_106538331 Show fit | 7.01 |
ENST00000390624.3
|
immunoglobulin heavy variable 3-48 |
|
chr14_-_106130061 Show fit | 5.53 |
ENST00000390602.3
|
immunoglobulin heavy variable 3-13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 71.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 45.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.5 | 15.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 13.6 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 11.9 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.8 | 10.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.2 | 8.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 8.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.8 | 7.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.6 | 6.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 63.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 19.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.9 | 17.6 | GO:0042611 | MHC protein complex(GO:0042611) |
1.4 | 15.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 12.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 8.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.0 | 7.8 | GO:0071757 | hexameric IgM immunoglobulin complex(GO:0071757) |
0.1 | 7.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 6.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 5.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 71.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 63.6 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 12.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.5 | 8.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 6.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 6.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 6.5 | GO:0046979 | TAP2 binding(GO:0046979) |
0.2 | 5.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 5.8 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 5.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 11.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 10.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 10.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 9.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 9.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 7.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 6.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 5.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 5.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 15.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 11.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 8.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 8.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 8.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 8.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 7.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 7.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 6.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 6.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |